Imaeda T, Mochizuki R, Kanematsu M, Yamawaki Y, Goto H, Seki M, Doi H, Saji S, Shimokawa K
Department of Radiology, Gifu University School of Medicine, Japan.
Abdom Imaging. 1995 Nov-Dec;20(6):534-40. doi: 10.1007/BF01256707.
The degrees and patterns of contrast enhancement of small hepatocellular carcinomas (HCCs) on dynamic magnetic resonance (MR) images were compared with those on hepatic arteriograms in 61 patients.
Dynamic MR imaging was performed within 1 week before hepatic angiography prior to treatment, 3-4 weeks after treatment, and then once every 1-3 months if necessary. Hepatic arteriography was carried out with a coaxial microcatheter inserted into the proper hepatic artery or its distal branches.
In 58 of 61 cases, the degrees of contrast enhancement of the tumor in dynamic MR imaging were roughly consistent with those in hepatic arteriography before treatment. In the remaining three cases, however, the tumors were depicted as hyperintense in the arterial dominant phase of the dynamic MR imaging, whereas the tumors were not detected by hepatic arteriography. The tumor detectability is 97% by dynamic MR imaging and 92% by hepatic arteriography. Furthermore, when an HCC nodule was not clearly enhanced by hepatic arteriography after treatment, it was possible by dynamic MR imaging to obtain accurate information on whether the HCC nodule had parasitic arteries.
Dynamic MR imaging was superior to hepatic angiography in contrast resolution. It was therefore considered to be useful in assessing the degrees and patterns of contrast enhancement of small HCCs before and after treatment.
比较了61例小肝细胞癌(HCC)在动态磁共振(MR)图像上的强化程度和模式与肝动脉造影的情况。
在治疗前肝血管造影前1周内、治疗后3 - 4周进行动态MR成像,必要时此后每1 - 3个月进行一次。采用同轴微导管插入肝固有动脉或其远端分支进行肝动脉造影。
61例中的58例,动态MR成像中肿瘤的强化程度与治疗前肝动脉造影大致一致。然而,在其余3例中,肿瘤在动态MR成像的动脉期呈高信号,而肝动脉造影未检测到肿瘤。动态MR成像的肿瘤检出率为97%,肝动脉造影为92%。此外,当治疗后肝动脉造影显示HCC结节强化不明显时,动态MR成像能够获取关于HCC结节是否存在寄生动脉的准确信息。
动态MR成像在对比分辨率方面优于肝血管造影。因此,它被认为有助于评估小HCC治疗前后的强化程度和模式。